AI-assisted mRNA cancer vaccine shows results in early study

DNA contains the fundamental genetic information of the body’s cells and cancer develops when changes occur in DNA that cause cells to grow uncontrollably.

Therefore, Paul first had the healthy DNA and tumour DNA of Rosie analyzed and then asked artificial intelligence to identify the differences between the two datasets. Based on those differences, Paul used AI to explore how a personalized cancer vaccine could be developed.

He shared this information with scientists at the University of New South Wales in Australia who then developed a special mRNA vaccine for Rosie.

Traditional vaccines are used to protect against viruses or bacteria whereas cancer vaccines aim to train the body’s immune system to recognize cancer cells and attack only those cells.

For this purpose, mRNA is used as a messenger to deliver instructions. Scientists inserted cancer cell proteins into the mRNA vaccine and administered it to Rosie.

After the vaccine was given, several of Rosie’s tumors shrank, the overall cancer burden in her body decreased and a noticeable improvement in her health was observed.

However, scientists emphasize that this is only a single case and not a formal clinical trial so it is too early to say whether this method will be equally effective in other animals or humans.

Artificial intelligence did not “discover” a cure for cancer instead, it played a supporting role while the vaccine development and all scientific procedures were completed by researchers.

Nevertheless, this development shows that the combination of DNA analysis, mRNA technology and artificial intelligence could make personalized treatments more accessible in the future.